• Unaudited NPAT for FY25 expected to outperform market consensus by 20%
• Full year sales expected to exceed market consensus
• Key drivers include sales growth, improved margins, and favourable currency movements

Clover Corporation Limited (ASX:CLV), a leading provider of innovative nutritional ingredients to the global food and infant formula markets, has provided a trading update for the financial year ended 31 July 2025. Based on preliminary, unaudited results, Net Profit After Tax (NPAT) for FY25 is expected to outperform market consensus. Key performance drivers are attributed to improved gross margins from higher value product mix, continued strong manufacturing performance at Melody Dairies, Ecuador oil now being delivered regularly for refining at Altona, and beneficial exchange rates on US and Euro invoiced customers. Clover Corporation CEO Peter Davey stated that this is a pleasing result, particularly the strong contribution from Ecuador, which is now firmly part of the company's global production footprint. The combination of improved margins from a favourable product mix and disciplined execution has delivered a result ahead of expectations. With a robust balance sheet, the business continues its momentum into FY26. The Company expects to release its audited FY25 full year results on Tuesday 23rd September 2025.

Unaudited NPAT for FY25 is expected to outperform market consensus ($5.5m) by approximately 20%. Full year sales are expected to exceed market consensus ($79.0m).

With a robust balance sheet, the business continues its momentum into FY26.